Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.

Also called NCT04502017

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 360 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04502017
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04502017. Randomized; no masking; primary purpose prevention. Start 2020-08-05 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
Acronym
FADE-DRT
Condition
Device-Related Thrombosis
Condition
Left Atrial Appendage Occlusion
Intervention (Drug)
ASA plus Clopidogrel
Intervention (Drug)
Genetic-Tailored AntiThrombotic Strategy
Intervention (Drug)
Half-Dose of novel OAC
Lead sponsor
Texas Cardiac Arrhythmia Research Foundation (class: other)

Record details

Record id
cardio:ct-nct04502017
Content hash
04b9868a143620d8b523ea80df2551a8ff278970ae790f9a56e408585b4b99d0